Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:QNTM - Post by User

Post by Bigmac4000on Apr 18, 2023 4:19pm
96 Views
Post# 35401545

Still waiting for the "other side of the story"

Still waiting for the "other side of the story" It has been 24 hours since the below legal notice was posted. Still crickets from the "Other side" . I would love an explanation and what the plan is going forward would also be nice. If there are two sides and they are not guilty lets here it. If it is silence because it will be a matter for the courts... lets here it. Say something. The stock did exactly what I predicted it would do, sadly i don't think it is done dropping. An interesting twist would be the two sides faking the legal battle to get the stock down more before partnering and watching it climb.... im totally kidding, we are screwed in my opinion (but this company is crooked enough nothing is out of the question) 

https://newsdirect.com/news/gbb-drink-lab-sends-a-cease-and-desist-demand-518246638

FSD Pharma Breached NDA with GBB After GBB Terminates Acquisition Discussions

Fort Lauderdale, FL --News Direct-- GBB Drink Lab

McapMediaWire -- GBB Drink Lab (“GBB” or the “Company”), a maker of the world’s first formulated drink that aids in rapid blood alcohol detoxification has issued a cease-and-desist demand to FSD Pharma (NASDAQ: HUGE) (“FSD”) a publicly traded biotechnology company that operates in the pharmaceutical research and development business.

GBB has a patented formula that accelerates the process of converting alcohol to sugar in the body. By enhancing the metabolic pathways that facilitate this process, the formula can help the body clear alcohol much faster than normal. The Company has been working on a proprietary drink for several years using its patented formula.

FSD Pharma entered into a binding Non-Disclosure Agreement (NDA) with GBB. The companies had ongoing discussions about an acquisition for many months that GBB has since terminated.

Mr. John Gulyas, Co-Founder of GBB Drink Lab, met with FSD and its principals over many months and shared proprietary information with the company that included without limitation, information created and developed by the company relating to composition, formulation, and methods of using the composition and formulations for reducing the effects associated with alcohol consumption in drink and other edible and nonedible forms.

Per the cease and desist letter sent to FSD, "Not only has FSD and its principals committed fraud by way of wrongfully inducing GBB Drink Lab into providing the Product and other confidential information, but FSD and its principals have also committed multiple breaches of the Agreement, including, but not limited to: (i) reverse-engineering the Product and/or other confidential information provided, in violation of Section 3 of the Agreement; and/or (ii) wrongfully asserting dominion over the Product and/or other confidential information (and all intellectual property rights pertaining thereto) by using such information to launch FSD’s recently announced Program”.

Mr. Jarrett Boon, Co-Founder and CEO of GBB Drink Lab, states that “FSD Pharma has violated the NDA, developed a product using the Company's formula, trade secrets, methods, and has used the stolen information to gain investors for its own stock. GBB is aggressively taking legal action against the theft of its confidential information and has demanded that FSD halt its product from being launched”.

Further evidence is supported that FSD Pharma has publicly announced the launch of a new research and development program targeting unmet medical needs for alcohol misuse. FSD Pharma has also announced the addition of Shark Tank investor and pitchman Kevin Harrington, and former Celsius (NASDAQ: CELH) CEO Gerry David to its Advisory Board to help commercialize its efforts.

 

GBB has demanded that "FSD immediately cease and desist the program, including, but not limited to, use of all confidential and/or proprietary information provided by GBB Drink Lab relating thereto."

About GBB Drink Lab

GBB Drink Lab started with a vision of making a positive impact by offering practical, evidence-based solution to reducing Blood Alcohol Content. The company’s product has been meticulously crafted to optimize your ability to sober up thus enabling you to escape an inebriated state. GBB Drink Lab leadership team includes accomplished serial entrepreneurs, a former senior executive from one of the world’s largest beverage companies, and an industry-leading expert in flavoring science and product formulation.

Contacts

Jarrett Boon, Co-Founder, CEO, GBB Drink Lab, Inc

Email: Jarrett@gbbdrinklab.com

Telephone: 602-456-1555

Contact Details

GBB Drink Lab

Jarrett@gbbdrinklab.com

Company Website

https://gbbdrinklab.com/

View source version on newsdirect.com: https://newsdirect.com/news/gbb-drink-lab-sends-a-cease-and-desist-demand-518246638

<< Previous
Bullboard Posts
Next >>